
Company valuation, historical trends, and peer comparisons.
According to Vaxart, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 63.56M. This represents a change of -21.75% compared to the average of 81.22M of the last 4 quarters.
The mean historical Enterprise Value of Vaxart, Inc. over the last ten years is 737.21M. The current 63.56M Enterprise Value has changed -91.38% with respect to the historical average. Over the past ten years (40 quarters), VXRT's Enterprise Value was at its highest in in the June 2020 quarter at 1.49B. The Enterprise Value was at its lowest in in the December 2025 quarter at 35.77M.
Average
737.21M
Median
267.17M
Minimum
35.77M
Maximum
2.94B
Discovering the peaks and valleys of Vaxart, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 4.07%
Maximum Annual Enterprise Value = 2.94B
Minimum Annual Increase = -88.85%
Minimum Annual Enterprise Value = 35.77M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 35.77M | -88.85% |
| 2024 | 320.67M | 18.39% |
| 2023 | 270.86M | -39.97% |
| 2022 | 451.18M | -84.63% |
| 2021 | 2.94B | 9.65% |
| 2020 | 2.68B | 4.07% |
| 2019 | 64.28M | -42.04% |
| 2018 | 110.90M | -57.91% |
| 2017 | 263.48M | 9.09% |
| 2017 | 241.52M | -50.90% |
The current Enterprise Value of Vaxart, Inc. (VXRT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
209.10M
5-year avg
802.88M
10-year avg
737.21M
Vaxart, Inc.’s Enterprise Value is less than Novavax, Inc. (1.70B), less than Vaxcyte, Inc. (9.43B), less than Valneva SE (539.31M), less than Vir Biotechnology, Inc. (1.69B), less than Arcturus Therapeutics Holdings Inc. (111.84M), greater than GeoVax Labs, Inc. (-1104814.00), less than Bavarian Nordic A/S (18.44B), less than Inovio Pharmaceuticals, Inc. (98.42M), less than Moderna, Inc. (88.12B), less than Ocugen, Inc. (230.57M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 1.70B | $1.59B | |
| 9.43B | $9.50B | |
| 539.31M | $516.79M | |
| 1.69B | $1.87B | |
| 111.84M | $280.39M | |
| -1104814.00 | $1.72M | |
| 18.44B | $2.96B | |
| 98.42M | $121.95M | |
| 88.12B | $88.55B | |
| 230.57M | $242.63M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vaxart, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Vaxart, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Vaxart, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Vaxart, Inc. (VXRT)?
What is the 3-year average Enterprise Value for Vaxart, Inc. (VXRT)?
What is the 5-year average Enterprise Value for Vaxart, Inc. (VXRT)?
How does the current Enterprise Value for Vaxart, Inc. (VXRT) compare to its historical average?